Welcome to our dedicated page for Flora Growth news (Ticker: FLGC), a resource for investors and traders seeking the latest updates and insights on Flora Growth stock.
Flora Growth Corp (FLGC) operates at the intersection of cannabis cultivation and pharmaceutical distribution, maintaining a vertically integrated model across 15+ countries. This page delivers essential updates about corporate milestones, regulatory compliance, and market expansion efforts.
Investors and industry observers will find comprehensive coverage of earnings reports, strategic partnerships, product launches, and operational developments. Our aggregation ensures you stay informed about FLGC’s commercial wholesale activities, consumer brand portfolio, and pharmaceutical-grade medical solutions.
Key updates include international supply chain advancements, CBD product innovations, and compliance achievements in regulated markets. Bookmark this page for real-time access to Flora Growth’s press releases and third-party analysis, curated to support informed decision-making.
Flora Growth Corp. (NASDAQ: FLGC) has been awarded the Best M&A Deal at Benzinga’s 2022 Cannabis Capital Conference in Chicago. This recognition highlights the company's strategic objectives, particularly the acquisition of JustCBD in February 2022, which added an established brand with over 300 products and a customer base exceeding 300,000. JustCBD generated US$28 million in audited revenue and US$7 million in EBITDA for fiscal year 2020. Flora executives will also be present at the conference to discuss the company’s growth and product offerings.
Flora Growth Corp. (NASDAQ: FLGC) has acquired substantially all assets of No Cap Hemp Co. without upfront payment. Instead, Flora will remit 10% of gross sales, capped at $2M, providing an immediate revenue stream. This acquisition enhances Flora's distribution in the US and adds approximately 75 SKUs, including the 'No Cap' and 'Moonblunt' trademarks. The deal aims to leverage No Cap's gas infusion technology and expand Flora's product portfolio, particularly in flower and smokeables, aligning with Flora's growth strategy.
Flora Growth Corp. (NASDAQ: FLGC) reported H1 2022 revenues of approximately $15.0 million, up 604% year-over-year, with gross profit reaching ~$7.0 million. The company reaffirms its 2022 revenue guidance of $35.0 million to $45.0 million, indicating a projected growth of 300% to 400% from 2021. Notably, the net loss increased to ~$32.7 million, largely due to a $16.0 million non-cash goodwill impairment related to the Vessel acquisition. Despite macro challenges, the company is optimistic about maintaining profitability as it expands its House of Brands and Life Sciences divisions, and manages overhead prudently.
Flora Growth Corp. (NASDAQ: FLGC) will host its H1 2022 earnings call on August 15, 2022, at 4:30 p.m. ET. The call will cover financial results for the six months ended June 30, 2022, and provide insights into the company’s commercial operations and strategies in the cannabis sector. Investors and analysts will have the opportunity to engage during a Q&A session following the presentation. The live webcast can be accessed through the company’s website.
Flora Growth Corp. (NASDAQ: FLGC) has entered a joint venture with Pharma Indigena Misak Manasr Sas, the largest indigenous tribe in Colombia. This partnership focuses on developing cannabis cultivation best practices, manufacturing, and marketing cannabis products. Flora will provide regulatory and business support while Manasr will assist in advancing cannabis exports from Colombia. The agreement is set for an initial term of three years, with a goal of establishing a long-term relationship.
Flora Growth Corp. supports a new Colombian bill proposed on
Flora Growth Corp. (NASDAQ: FLGC) has appointed Elshad Garayev as its new Chief Financial Officer, effective after the company files its mid-year financial results. Garayev, with over 25 years of experience from Amazon, Boeing, and BP, will focus on enhancing financial discipline and governance at Flora. He aims to optimize resource utilization and aid the company's growth strategy in the cannabis sector. The current CFO, Lee Leiderman, will transition to an advisory role to prioritize his health and family.
Flora Growth Corp. (NASDAQ: FLGC) announced that shareholders approved all proposals at the annual meeting held on July 5, 2022. Key proposals included the election of seven Board members, re-appointment of auditors, and approval of the 2022 Incentive Compensation Plan. Notably, Brandon Konigsberg was elected to the Board and will also serve as Chair of the Audit Committee. His extensive experience in finance, including a 24-year career at JP Morgan Chase, is expected to enhance Flora's financial growth and governance.
Flora Growth Corp. (NASDAQ: FLGC) congratulates President-Elect Gustavo Petro and the Humane Colombia Party following their election victory. The company expresses optimism about progressive cannabis legislation in Colombia that could boost the legal market. Flora’s CEO highlights Colombia's potential for high-quality cannabis production. With a 249-acre facility in Bucaramanga, the company anticipates 90% of its revenue from international markets. In 2021, Colombia exported $1.5 billion in cut flowers, positioning it as a significant player in global exports, similar to cannabis prospects.
Flora Growth Corp. (NASDAQ: FLGC) announced a share repurchase program of up to $5 million to enhance shareholder value amid market fluctuations. CEO Luis Merchan noted that the company aims to utilize available cash strategically as the stock price has dipped due to broader financial market weakness and significant selling by early shareholders. The repurchase program is expected to reinforce confidence in Flora's strong brand portfolio and growth strategies. Repurchases may occur through various means depending on market conditions.